Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2007; 98(01): 3-5
DOI: 10.1160/TH07-04-0313
DOI: 10.1160/TH07-04-0313
Anniversary Issue Contribution
Fathers of modern coagulation
Further Information
Correspondence to:
Dougald M. Monroe
UNC Medical School – Hematology/Oncology
932 Mary Ellen Jones, CB#7035 Chapel Hill
North Carolina 27599–7035, USA
Phone: +19199663311
Fax: +19199667639
Email: dmonroe@med.unc.edu
Publication History
Received
12 April 2007
Accepted
11 May 2007
Publication Date:
29 November 2017 (online)
#
-
References
- 1 Morawitz P, (translated by Hartmann RC, Guenther PF. editors). The Chemistry of Blood Coagulation. Springfield, Illinois: Charles C, Thomas; 1958
- 2 Patek AJ, Taylor FHL. Some properties of a substance obtained from normal human plasma effective in acceleration the coagulation of hemophilic blood. J Clin Invest 1937; 16: 113-124.
- 3 Robbins KC. A study of the conversion of fibrinogen to fibrin. Am J Physiol 1944; 142: 581-588.
- 4 Hougie C. The waterfall-cascade and autoprothrombin hypotheses of blood coagulation: personal reflections from an observer. J Thromb Haemost 2004; 2: 1225-1233.
- 5 Graham JB. Stuart Factor: discovery and designation as factor X. J Thromb Haemost 2003; 1: 871-877.
- 6 Owren PA. The coagulation of blood: Investigations on a new clotting factor. Acta Med Scand. 1947 Suppl:194.
- 7 Wagner RH, Roberts HR, Webster WP. et al. Glycine-precipitated antihemophilic factor concentrates and their clinical use. Thromb Diath Haemorrh Suppl 1968; 35: 41-48.
- 8 Pavlovsky A. Contribution to the pathogenesis of hemophilia. Blood 1947; 2: 185-191.
- 9 Aggeler PM, White SG, Glendening MB. et al. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. Proc Soc Exp Biol Med 1952; 79: 692-694.
- 10 Biggs R, Douglas AS, Macfarlane RG. et al. Christmas disease: a condition previously mistaken for haemophilia. Br Med J 1952; 2: 1378-1382.
Correspondence to:
Dougald M. Monroe
UNC Medical School – Hematology/Oncology
932 Mary Ellen Jones, CB#7035 Chapel Hill
North Carolina 27599–7035, USA
Phone: +19199663311
Fax: +19199667639
Email: dmonroe@med.unc.edu
-
References
- 1 Morawitz P, (translated by Hartmann RC, Guenther PF. editors). The Chemistry of Blood Coagulation. Springfield, Illinois: Charles C, Thomas; 1958
- 2 Patek AJ, Taylor FHL. Some properties of a substance obtained from normal human plasma effective in acceleration the coagulation of hemophilic blood. J Clin Invest 1937; 16: 113-124.
- 3 Robbins KC. A study of the conversion of fibrinogen to fibrin. Am J Physiol 1944; 142: 581-588.
- 4 Hougie C. The waterfall-cascade and autoprothrombin hypotheses of blood coagulation: personal reflections from an observer. J Thromb Haemost 2004; 2: 1225-1233.
- 5 Graham JB. Stuart Factor: discovery and designation as factor X. J Thromb Haemost 2003; 1: 871-877.
- 6 Owren PA. The coagulation of blood: Investigations on a new clotting factor. Acta Med Scand. 1947 Suppl:194.
- 7 Wagner RH, Roberts HR, Webster WP. et al. Glycine-precipitated antihemophilic factor concentrates and their clinical use. Thromb Diath Haemorrh Suppl 1968; 35: 41-48.
- 8 Pavlovsky A. Contribution to the pathogenesis of hemophilia. Blood 1947; 2: 185-191.
- 9 Aggeler PM, White SG, Glendening MB. et al. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. Proc Soc Exp Biol Med 1952; 79: 692-694.
- 10 Biggs R, Douglas AS, Macfarlane RG. et al. Christmas disease: a condition previously mistaken for haemophilia. Br Med J 1952; 2: 1378-1382.